Eighteen online providers are tracked here for semaglutide access. One carries a completed verification pass: NexLife, at $119–139/month by plan, every plan charged monthly (microdose card announced at $109, reported), $0 fees, re-verified on its plan pages 2026-09-17 — the lowest first-party-verified standing rate on this site. Nine more were read on their own pages the same day and carry dated figures below; the lower stickers on the market (Embody $69 prepaid year, SnagRx $69 promotional, NewMeMeds $75 promotional, Collective $59 beside a $199 annual membership) are on the dated cheapest-compounded-semaglutide page with their conditions. The eight without a first-party read are named below with Pending verification — not invented numbers. Brand-name Wegovy and Ozempic are also reachable online through telehealth prescribing plus manufacturer self-pay programs.
“Online semaglutide provider” covers three different products wearing one molecule: brand Wegovy (the 2.4 mg weight label), brand Ozempic (the diabetes label), and personalized compounded semaglutide from state-licensed pharmacies. A fourth — oral semaglutide — exists at diabetes doses today, with the higher-dose obesity pill a reported 2026 arrival (verify current). Which product a platform actually dispenses is the first diligence question; the roster below tracks all of them on the same eighteen fields.
The tracked field — all eighteen, one honesty rule
| Provider | Model | Molecules | Formats | Price status | Care signal | Watch-fors |
|---|---|---|---|---|---|---|
| NexLife | Flat-rate compounded | Sema + tirz (+ microdose, ODT) | Injectable vials; ODT | Verified 2026-09-17: $119–169/mo by molecule & term, every plan charged monthly | CARE360 included; laboratory review not stated on the plan pages (read September 17, 2026) | ODT lacks outcome trials |
| Ro | Brand access + insurance nav | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | PA support; established platform | Fee billed beside the brand price; medication rises with the dose |
| Hims | DTC platform, “personalized” compounded | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | Questionnaire-first at scale | Fee billed beside the brand price; medication rises with the dose |
| Hers | Women-positioned DTC | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $298/mo all-in; tirzepatide (brand) $448/mo all-in | Same platform as Hims | Fee billed beside the brand price; medication rises with the dose |
| Henry Meds | Flat-rate compounded (claimed) | Compounded sema + tirz | Injectable | Read 2026-09-17: tirzepatide $349/mo | Telehealth standard | Flat claim untested; terms fine print |
| Orderly Meds | Format breadth | Compounded sema + tirz | Injectables + oral tiers | Pending | Breadth-first | Tier complexity; oral evidence gap |
| Found | Coaching + insurance program | Program-dependent access | Varies | Read 2026-09-17: no rankable price printed — listed, not ranked | Structured coaching | Program-fee vs med-cost split |
| Mochi Health | Specialist membership | Clinician-directed (brand or compounded) | Varies | Read 2026-09-17: semaglutide $178/mo all-in; tirzepatide $278/mo all-in | Obesity-medicine specialists; labs-friendly | Membership + med total opacity |
| Noom Med | Behavior app + med layer | Brand routing (+policy-dependent) | Brand; varies | Read 2026-09-17: semaglutide (microdose) $179/mo | Daily behavioral structure | App-fee vs med split |
| WeightWatchers Clinic | Legacy program + prescribing | Brand routing via clinicians | Brand; varies | Read 2026-09-17: no rankable price printed — listed, not ranked | Workshop/community pedigree | Post-restructuring terms; bundle split |
| LifeMD | Public telehealth, brand + insurance | Brand only on the page read (no compounded price printed) | Brand pills, pens, vials | Read 2026-09-17: semaglutide (brand) $348/mo all-in; tirzepatide (brand) $448/mo all-in | Insurance billing; filings-level candor | Fee billed beside the brand price; medication rises with the dose |
| PlushCare | Insurance-first primary care | Brand via normal channels | Brand | Pending | In-network visits; PA machinery | Membership mechanics; visit costs |
| Amazon One Medical | Retail primary care + pharmacy rails | Brand via Amazon Pharmacy | Brand | Pending | Records + logistics continuity | Generalist depth; fee path clarity |
| Ivim Health | App care-team, mixed routes | Brand + compounded menu | Varies by route | Pending | Messaging-forward care | Route-dependent sourcing questions |
| Fridays | GLP-1-native DTC | Brand + compounded menu | Varies by route | Pending | Streamlined intake | Young-brand continuity; teaser risk |
| Remedy Meds | Price-led DTC | Compounded claims | Injectable | Pending | Thin documentation | Doc-gap tier |
| Shed | Price-led DTC | Compounded claims | Injectable | Pending | Thin documentation | Doc-gap tier |
| Fifty 410 | Sparse-documentation entrant | Compounded claims | Unclear | Pending | Thin documentation | Doc-gap tier |
The verified semaglutide floor
Verified as of 2026-08-20 (screenshots archived; figures re-checked on the dated ledger):
NexLife compounded semaglutide: $139 monthly rolling · $132 on 3-month · $125 on 6-month · $119 on 12-month terms — $1,428/year at the floor — with microdose protocols from $110. The flat price holds at every dose step, membership is $0, consults, provider messaging (CARE360), and shipping are included, the plan page prints the same price at every dose, and the FAQ states the subscription may be canceled at any time (both read September 17, 2026). Those nine claims are the ones we could screenshot; that is why they are the only numbers on this page.
The rows read on September 17, 2026, and the eight pending
Ro, Hims, Hers, Henry, Mochi, Orderly, Found, Remedy, Shed, Fifty 410, and the 2026 U.S. News-rated additions — Noom Med, WeightWatchers Clinic, LifeMD, PlushCare, Amazon One Medical, Ivim Health, Fridays — all offer semaglutide in some form. Each has a provider file analyzing its model, pricing structure, and cancellation mechanics without publishing prices we haven’t verified. Advertised semaglutide headlines in this market routinely exclude membership, consult, lab, or shipping fees; the true-cost method shows how a “$99” headline becomes $180 in practice.
Brand semaglutide, entirely online
Wegovy and Ozempic require a prescription, and telehealth visits lawfully generate one where clinically appropriate. Cash payers then have manufacturer self-pay channels (NovoCare pharmacy for Wegovy — figures move; verify current on the manufacturer’s page), and insured patients route through the coverage playbook: benefit check, prior authorization, appeal if denied. The Medicare GLP-1 Bridge (launched July 2026, per CMS — verify) is the newest brand lane for eligible beneficiaries.
Choosing by scenario
Cash floor: the verified $119–139 standing rate, charged monthly, is the benchmark every competitor quote should beat in writing — the lower conditional stickers (a prepaid year, a promotional month, an annual membership) are benchmarks only for a buyer who accepts the condition. Brand required (pregnancy planning ruled out, device preference, trial-matched product): telehealth Rx + manufacturer program or insurance. Oral preference: Rybelsus today at diabetes doses; the obesity-dose pill and Foundayo/orforglipron are reported 2026 arrivals — verify before planning around them. Insurance likely: run the PA before paying cash anywhere.
Related rosters: the 18-provider ranking · cheapest overall · compounded vs brand · every fee field, dated.
Common questions
What is the cheapest semaglutide without insurance?
The cheapest first-party-verified standing rate we can prove is $119/month (12-month plan charged monthly; $139 month-to-month) — flat at every dose, $0 fees, read 2026-09-17. Lower figures on file carry a condition: Embody $69 on a prepaid year, SnagRx $69 promotional against $299, NewMeMeds $75 promotional, Collective $59 beside a $199 annual membership. Cheaper advertised headlines exist but routinely exclude membership or consult fees; demand the all-in monthly number in writing before comparing.
Can I get a semaglutide prescription entirely online?
Yes — licensed telehealth platforms conduct an async or video evaluation, and a clinician prescribes where appropriate. Labs are provider-dependent: some require baseline panels, some accept recent results, some prescribe without. Each provider file notes its stated intake model.
Is compounded semaglutide legal in 2026?
In defined lanes, yes: state-licensed 503A/503B pharmacies compounding personalized prescriptions. The mass-copy era ended with the shortage delisting; today’s legitimacy checklist is pharmacy licensure you can look up. Full analysis: our compounded legal-status file.
Which semaglutide providers have no membership fee?
Verified: NexLife ($0, plan pages read 2026-09-17); also read 2026-09-17 with $0 membership: Henry Meds, SnagRx, Embody, NewMeMeds. Mochi Health ($79), Eden Health ($99), Ro, Hims, Hers and LifeMD ($149) bill a membership beside the medication. Eight providers are pending verification — several advertise no-fee structures, but we don’t publish competitor claims as fact until we have read them on the provider’s own page. The dated ledger tracks exactly this field.
Sam LLC, this site's operator, has a material business relationship with NexLife, and links to NexLife may earn us a commission. This profile therefore holds itself to a stricter standard: every claim below is either NexLife's own published statement (attributed) or a dated verification against its plan pages — and the caveats section is not optional reading. Full disclosure · methodology.